Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 383 of 1,261
  1. US 10844040

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  2. US 10842980

    Systems, devices, and/or methods for managing transdermal patches

    N Brereton Medical Technologies, LLC · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  3. US 10842908

    Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  4. US 10842814

    Use of low dose arsenic for preserving genomic integrity

    The Board of Regents of the University of Texas System · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  5. US 10842791

    Small molecule inhibitors of EGFR and PI3K

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  6. US 10842801

    Optimizing mifepristone absorption

    Corcept Therapeutics Incorporated · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  7. US 10845366

    Predictive markers for polyamine inhibitor cancer therapies

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  8. US 10844379

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  9. US 10842800

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  10. US 10844090

    Hemiasterlin derivatives for conjugation and therapy

    Sutro Biopharma, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  11. US 10842737

    Vaginal probiotic products and related processes

    Grace Procurements LLC · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  12. US 10844384

    Glucokinase (GCK) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  13. US 10842664

    Skin-like condoms having active ingredients to enhance a male erection and a female arousal

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  14. US 10844058

    Valbenazine salts and polymorphs thereof

    Neurocrine Biosciences, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  15. US 10844064

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  16. US 10844076

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Nektar Therapeutics · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  17. US 10844376

    Structurally-enhanced miRNA inhibitor S-TuD

    GeneDesign, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  18. US 10844357

    Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

    The Board of Regents for Oklahoma State University · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  19. US 10844137

    Anti-CTLA-4 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  20. US 10842826

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  21. US 10844387

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  22. US 10842743

    Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents

    The Regents of the University of California · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  23. US 10835490

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  24. US 10835549

    Polyplexes

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.